epoetin alfa-epbx 20000 [iU] / mL Injection 1 mL (Retacrit)
Comprehensive product details for sourcing and verification.
| NDC 11 | 00069-1311-10 |
|---|---|
| Product NDC | 00069-1311 |
| Generic Drug Name | epoetin alfa-epbx |
| Brand Name | Retacrit |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc |
| Strength | 20000 [iU] / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous; Subcutaneous |
| Package Quantity | 10 Vial, Multi-Dose |
| Package Description | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-10) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| Active Ingredients | Epoetin |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
epoetin alfa-epbx 20000 [iU] / mL Injection is tracked under NDC 00069-1311-10 and rolls up into product family 00069-1311. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 10 Vial, Multi-Dose.
- Manufacturer: Pfizer Laboratories Div Pfizer Inc.
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Public sources include public product-identification and FDA approval sources for RETACRIT (epoetin alfa-epbx) tied to NDC 0069-1311-10.
Drug Shortage Index family
View Epoetin alfa-epbx in the Drug Shortage IndexCompare related exact NDC products and family-level shortage context for Epoetin alfa-epbx.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
epoetin alfa-epbx 20000 [iU] / mL Injection 1 mL (Retacrit), NDC 00069-1311-10, is a Pfizer Laboratories Div Pfizer Inc 20000 [iU] / mL injection presentation packaged as 10 Vial, Multi-Dose. Historical public shortage information is available for this exact presentation.
NDC search formats
- Canonical NDC 11: 00069-1311-10.
- Digits-only NDC 11: 00069131110.
- Possible 10-digit display format: 0069-1311-10 (0069131110).
Helpful product links
- Search by brand name: Retacrit.
- Exact NDC 11: 00069-1311-10.
- Product family NDC: 00069-1311.
Related shortage research
If your team is researching the broader shortage picture, the family page groups related exact NDC items, brand variations, and family-level shortage context in one place.